Evaluating the effectiveness of the Food and Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.

Similar Items

• Evaluating the effectiveness of the Food And Drug Administration Modernization Act hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
  Published: (2001)
• FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet meets standards for safety and efficacy, March 1, 2005.
  Published: (2005)
• Preliminary report of the survey on drugs for rare disease /
  Published: (1982)
• The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
  Published: (2007)
• The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report /
  Published: (1992)